HK1025317A1 - Quinoxalinediones - Google Patents
QuinoxalinedionesInfo
- Publication number
- HK1025317A1 HK1025317A1 HK00104471A HK00104471A HK1025317A1 HK 1025317 A1 HK1025317 A1 HK 1025317A1 HK 00104471 A HK00104471 A HK 00104471A HK 00104471 A HK00104471 A HK 00104471A HK 1025317 A1 HK1025317 A1 HK 1025317A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- relates
- derivatives
- quinoxalinediones
- quinoxalinedione
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1997/000995 WO1997032873A1 (en) | 1996-03-09 | 1997-02-27 | Quinoxalinediones |
GBGB9715783.8A GB9715783D0 (en) | 1997-02-27 | 1997-07-25 | Quinoxalinediones |
PCT/EP1998/001275 WO1998038186A1 (en) | 1997-02-27 | 1998-02-24 | Quinoxalinediones |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1025317A1 true HK1025317A1 (en) | 2000-11-10 |
Family
ID=10816496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00104471A HK1025317A1 (en) | 1997-02-27 | 2000-07-20 | Quinoxalinediones |
Country Status (14)
Country | Link |
---|---|
US (1) | US6333326B1 (uk) |
KR (1) | KR100375112B1 (uk) |
AP (1) | AP982A (uk) |
AU (1) | AU723467B2 (uk) |
DZ (1) | DZ2437A1 (uk) |
EA (1) | EA001658B1 (uk) |
GT (1) | GT199800045A (uk) |
HK (1) | HK1025317A1 (uk) |
IL (1) | IL131120A0 (uk) |
IS (1) | IS5142A (uk) |
MA (1) | MA26474A1 (uk) |
OA (1) | OA11189A (uk) |
PL (1) | PL335501A1 (uk) |
UA (1) | UA58534C2 (uk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0110961A (pt) * | 2000-05-19 | 2004-06-29 | Merck Patent Gmbh | Derivados de triazol |
US20040082543A1 (en) * | 2002-10-29 | 2004-04-29 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain |
WO2008088820A2 (en) | 2007-01-16 | 2008-07-24 | The Johns Hopkins University | Glutamate receptor antagonists and methods of use |
CN106928157A (zh) | 2007-05-17 | 2017-07-07 | 株式会社半导体能源研究所 | 三唑衍生物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5158846A (en) | 1990-10-29 | 1992-10-27 | Olin Corporation | Electrostatic color printing system utilizing an image transfer belt |
IT1243990B (it) * | 1990-10-30 | 1994-06-28 | Minnesota Mining & Mfg | Procedimento per preparare prodotti del bisfenolo fluorene |
JP2550456B2 (ja) * | 1990-11-06 | 1996-11-06 | 山之内製薬株式会社 | 縮合ピラジン誘導体 |
GB9605027D0 (en) | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
-
1997
- 1997-02-27 AP APAP/P/1998/001201A patent/AP982A/en active
-
1998
- 1998-02-24 IL IL13112098A patent/IL131120A0/xx unknown
- 1998-02-24 EA EA199900688A patent/EA001658B1/ru not_active IP Right Cessation
- 1998-02-24 PL PL98335501A patent/PL335501A1/xx unknown
- 1998-02-24 UA UA99084653A patent/UA58534C2/uk unknown
- 1998-02-24 US US09/367,303 patent/US6333326B1/en not_active Expired - Fee Related
- 1998-02-24 KR KR10-1999-7007786A patent/KR100375112B1/ko not_active IP Right Cessation
- 1998-02-24 AU AU68279/98A patent/AU723467B2/en not_active Ceased
- 1998-02-25 DZ DZ980047A patent/DZ2437A1/xx active
- 1998-02-25 MA MA24980A patent/MA26474A1/fr unknown
- 1998-02-26 GT GT199800045A patent/GT199800045A/es unknown
-
1999
- 1999-07-30 IS IS5142A patent/IS5142A/is unknown
- 1999-08-23 OA OA9900192A patent/OA11189A/en unknown
-
2000
- 2000-07-20 HK HK00104471A patent/HK1025317A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA199900688A1 (ru) | 2000-04-24 |
MA26474A1 (fr) | 2004-12-20 |
GT199800045A (es) | 1999-08-20 |
AU6827998A (en) | 1998-09-18 |
OA11189A (en) | 2003-05-14 |
UA58534C2 (uk) | 2003-08-15 |
KR20000075717A (ko) | 2000-12-26 |
AU723467B2 (en) | 2000-08-24 |
DZ2437A1 (fr) | 2003-01-11 |
IS5142A (is) | 1999-07-30 |
EA001658B1 (ru) | 2001-06-25 |
US6333326B1 (en) | 2001-12-25 |
KR100375112B1 (ko) | 2003-03-08 |
AP982A (en) | 2001-07-16 |
IL131120A0 (en) | 2001-01-28 |
PL335501A1 (en) | 2000-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999026927A3 (en) | Metabotropic glutamate receptor antagonists for treating central nervous system diseases | |
IL157491A0 (en) | Heteropolycyclic compounds and pharmaceutical compositions containing the same | |
EP1595871A3 (en) | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases | |
TWI265928B (en) | A61k 31/4025 200601 a i htw a61p 25/00 200601 a n htw | |
IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
IL114599A (en) | Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them | |
JO2359B1 (en) | Benzathene derivatives as agents for modulation of GABA A receptor | |
MY139523A (en) | Ziprasidone composition and synthetic controls | |
EP1918287A3 (en) | LPA receptor agonists and antagonists and methods of use | |
ZA200201788B (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for the treatment of pain. | |
HUP0104018A3 (en) | Pharmaceutical compositions containing antagonists of nr2b subtype of nmda receptor for treating neurological disorders | |
GB9815618D0 (en) | Treatment of dyskinesia | |
HK1023770A1 (en) | Chalcones having antiproliferative activity. | |
YU57999A (sh) | N-triazolil-2-indolkarboksamidi i njihova primena kao agonista za cck-a | |
HK1049153A1 (en) | Adenosine receptor antagonists and methods of making and using the same | |
BG104038A (en) | Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing | |
WO2002039118A8 (en) | Screening methods for bone morphogenetic mimetics | |
HK1025317A1 (en) | Quinoxalinediones | |
BG103649A (en) | Method for the preparation of eprosartan | |
BG102229A (en) | Endothelium receptor antagonists | |
BG103650A (en) | Method for the preparation of eprosartan | |
EP1335922A4 (en) | NOVEL 4'-DEMETHYL-4'-O-SUBSTITUE-1-DEOXYPODOPHYLLOTOXIN DERIVATIVE, GEOMETRIC ISOMER THEREOF, PROCESS FOR PREPARING THE SAME, AND ANTI-CANCER COMPOSITION COMPRISING SAID DERIVATIVE | |
PL338681A1 (en) | Derivatives of 1,3-dioxolo/4,5-h/2,3-benzodiazepins as inhibitors of ampa/cainate receptors | |
ZA98682B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders | |
IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20070224 |